Inspire Veterinary provides shareholder update on momenum year-to-date

Accomplishments to date include: The highest new client growth in more than a year, with clinics across the portfolio achieving positive new client growth compared to 2024 and prior. Completion of an enterprise-wide rollout of cloud-based Electric Medical Record and Practice Management Software across all clinics. Deployment of Artificial Intelligence-based transcription for medical notes, enabling enhanced productivity and efficiency across the company’s business units. Record breaking veterinarian hiring with nine new doctor starts since the beginning of 2025. Completion of the company’s fifth acquisition in the state of Florida. Signing of a Letter of Intent for a planned acquisition of the company’s first location in New Jersey, which will be the Company’s 15th location nationwide. A return to positive revenue comps as reported in Q2 2025. Deployment of infrastructure investments including a new talent management system; new engagement, recognition and incentive-based pay structures; new finance professionals and enhancements to the company’s purchase and inventory management systems; new investor relations and investment banking partnerships. CEO Kimball Carr commented, “Inspire is back to growth and we are better positioned for success than ever before. Following our letter to shareholders earlier in 2025, we are very excited to continue to share the progress Inspire is making and how we’re seeing the benefits of our collective work reflected in our business. The company is consistently delivering positive results, new growth across a wide array of measures and KPIs ,and there is maturity in our systems and leadership team, which are delivering results on a daily basis. We’re looking forward to finishing strong in 2025 and springing forward toward increased growth in 2026.”